Anti-Müllerian hormone, better known as AMH, has become one of the most frequently ordered tests in fertility evaluations over the past decade. For women over 35 who are thinking about their reproductive future — whether actively trying to conceive or simply gathering information — AMH can offer a useful window into ovarian reserve. But like most hormonal tests, it tells a specific story, not the whole story.
Understanding what AMH measures, what it doesn’t measure, and how to contextualize results within a broader fertility evaluation can help women approach this information with both clarity and appropriate perspective. A number on a lab report is most meaningful when interpreted by a clinician who understands the full picture of your health and goals.
This article walks through the science behind AMH testing, what current research says about its predictive value, its limitations, and what the conversation with your healthcare provider might look like after you receive results.
What Current Research Shows About AMH and Age
AMH is produced by small follicles in the ovaries and is considered one of the most reliable markers of ovarian reserve — meaning the quantity of remaining eggs. Unlike FSH (follicle-stimulating hormone), which fluctuates throughout the cycle, AMH levels remain relatively stable regardless of where you are in your cycle, making it convenient to test at any time.
Research consistently shows that AMH levels decline with age. According to data from the National Institute of Child Health and Human Development, the rate of decline accelerates after approximately age 35–37 in most women, though individual trajectories vary significantly. Some women in their late 30s maintain AMH levels comparable to women in their early 30s; others experience earlier decline. This variability is one reason why age alone is considered an incomplete picture of ovarian reserve.
It’s important to understand that AMH measures quantity of remaining follicles, not egg quality. This distinction matters enormously in fertility discussions, because egg quality — which also declines with age — is often a more significant determinant of conception success and pregnancy outcomes than egg quantity alone.
What AMH Testing Can and Cannot Tell You
AMH is a useful tool for ovarian reserve assessment, but it has well-documented limitations that are worth understanding before attaching too much meaning to a single result.
What AMH Can Indicate
A lower AMH level for a given age suggests a smaller remaining pool of follicles, which may mean fewer eggs retrievable during IVF and potentially a shorter reproductive window. Fertility specialists often use AMH to inform decisions about IVF protocols — for example, medication dosing for ovarian stimulation. It can also be a useful baseline measurement for monitoring ovarian reserve over time.
Higher AMH levels, on the other hand, are associated with a larger follicle pool. In some cases, very high AMH may indicate polycystic ovarian syndrome (PCOS), which has its own implications for fertility evaluation.
What AMH Cannot Predict
Research has not established AMH as a reliable predictor of spontaneous conception rates. Studies have found that women with low AMH can and do conceive naturally, including women over 35. AMH also cannot assess egg quality, uterine receptivity, male factor fertility, or the many other variables that influence whether a pregnancy occurs. A comprehensive fertility evaluation that looks at multiple factors gives a much fuller picture than AMH alone.
Additionally, AMH results can vary between laboratories due to differences in assay methodology, and interpretation can vary among clinicians. If you receive a result that concerns you, getting a second opinion or having results reviewed by a reproductive endocrinologist is entirely reasonable.
The Role of Antral Follicle Count Alongside AMH
Fertility specialists often pair AMH testing with an antral follicle count (AFC) — a transvaginal ultrasound that counts small resting follicles visible in both ovaries at the beginning of the cycle. AFC gives a real-time visual complement to the hormonal information AMH provides, and the two together offer a more robust assessment of ovarian reserve than either does alone.
If you’re working with a reproductive endocrinologist, you may find that they order both tests as part of an initial fertility workup, alongside FSH and estradiol on cycle day 2 or 3. Together, these data points help paint a picture of ovarian function that informs next-step conversations — whether that’s continuing to try naturally, exploring interventional options, or gathering more information before making decisions.
For a broader overview of what a first fertility consultation might involve, our article on preparing for your first fertility appointment after 35 offers helpful context on what to expect.
Interpreting Your AMH Results: A Framework for the Conversation
AMH reference ranges vary somewhat by lab and by the specific assay used, but a general framework that many clinicians use looks something like this:
For women in their mid-to-late 30s, an AMH above approximately 1.0–1.5 ng/mL is often considered reassuring, while values below 1.0 ng/mL may prompt more detailed evaluation. Values below 0.3–0.5 ng/mL are sometimes described as “low” or “diminished” ovarian reserve. However, these are rough benchmarks — what matters most is how results are interpreted in the context of your age, your clinical history, your goals, and the full fertility evaluation picture.
If your AMH comes back lower than expected, it’s worth taking time to process the result before making major decisions. Low AMH at 37 or 39 does not mean conception is impossible — it may mean the conversation with a reproductive endocrinologist becomes more time-sensitive, or it may inform decisions about whether to pursue fertility preservation or assisted reproductive technologies sooner rather than later.
Fertility Preservation and AMH After 35
For women over 35 who are not yet ready to pursue pregnancy but want to understand their options, AMH testing is often one of the starting points in a fertility preservation conversation. Egg freezing (oocyte cryopreservation) has become increasingly available and technically refined over the past decade, and AMH helps clinicians assess how a patient might respond to ovarian stimulation before that process begins.
Lower AMH doesn’t preclude egg freezing, but it may affect how many eggs are retrievable in a single cycle. A reproductive endocrinologist can discuss realistic expectations for egg freezing based on AMH, AFC, age, and individual response to stimulation.
For those weighing these decisions, our article on what to know about egg freezing after 35 explores the conversation many women have at this stage.
Frequently Asked Questions
Can I get an AMH test from my regular OB/GYN?
Many OB/GYNs and general practitioners are comfortable ordering AMH testing, particularly for women over 35 who are thinking about fertility. If your provider isn’t familiar with it, asking for a referral to a reproductive endocrinologist is a reasonable next step. AMH is a standard part of most fertility workups.
How often should I have my AMH tested?
There’s no universal recommendation for repeat AMH testing frequency. If you received a result that was in a normal range and you’re not actively trying to conceive, annual or biennial testing may provide useful trend data. If you received a lower result and are actively trying, working with a reproductive specialist who can guide the timing and interpretation of follow-up testing is advisable.
Does low AMH mean I’m in early menopause?
Not necessarily. Low AMH is associated with diminished ovarian reserve, but it doesn’t by itself indicate premature ovarian insufficiency (POI) or early menopause. POI is diagnosed based on a combination of factors including FSH levels, menstrual patterns, symptoms, and age. If you have concerns about premature ovarian insufficiency, a full hormonal evaluation with a specialist is the appropriate path.
Can lifestyle changes improve my AMH?
Current evidence does not support the idea that lifestyle changes can significantly increase AMH levels. Ovarian reserve reflects the biological pool of follicles remaining, which cannot be meaningfully replenished. That said, some research suggests that certain nutritional factors (like adequate vitamin D) may be associated with AMH levels, though this is an evolving area and the clinical implications remain uncertain. Any lifestyle-related decisions should be discussed with a healthcare provider.
Key Takeaways
- AMH is a reliable marker of ovarian reserve (egg quantity) and can be tested at any point in the cycle, making it a practical and commonly used tool in fertility evaluations.
- AMH declines with age, but individual variation is substantial — a single result should be interpreted in the context of the full fertility evaluation, not in isolation.
- AMH does not measure egg quality and is not a reliable predictor of spontaneous conception rates; women with low AMH can and do conceive naturally.
- Pairing AMH with antral follicle count (AFC) and other cycle-day hormonal tests gives the most complete picture of ovarian reserve.
- If you receive results that concern you, a reproductive endocrinologist is the best resource for interpreting results and discussing next steps in the context of your individual situation and goals.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.